Pharma & Healthcare
Global RNA Stabilizers Market Research Report 2026
- Feb 03, 26
- ID: 697733
- Pages: 134
- Figures: 133
- Views: 6
This report delivers a comprehensive overview of the global RNA Stabilizers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RNA Stabilizers. The RNA Stabilizers market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global RNA Stabilizers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RNA Stabilizers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Takara Bio
Zymo Research
NZYtech
Omega Bio-Tek
Vazyme
BioEntist
Genetix Biotech Asia
SRL
G-Biosciences
New England Biolabs
Dutscher
NCM Biotech
Beyotime
Yeasen
YaJi Biological
Maokangbio
Segment by Type
Solution-Based Stabilizers
Spray or Coating-Based Stabilizers
Solid Phase Stabilizers
by Application
Molecular Biology
Genomics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for RNA Stabilizers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines RNA Stabilizers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global RNA Stabilizers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RNA Stabilizers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Takara Bio
Zymo Research
NZYtech
Omega Bio-Tek
Vazyme
BioEntist
Genetix Biotech Asia
SRL
G-Biosciences
New England Biolabs
Dutscher
NCM Biotech
Beyotime
Yeasen
YaJi Biological
Maokangbio
Segment by Type
Solution-Based Stabilizers
Spray or Coating-Based Stabilizers
Solid Phase Stabilizers
by Application
Molecular Biology
Genomics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for RNA Stabilizers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines RNA Stabilizers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 RNA Stabilizers Market Overview
1.1 Product Definition
1.2 RNA Stabilizers by Type
1.2.1 Global RNA Stabilizers Market Value by Type: 2025 vs 2032
1.2.2 Solution-Based Stabilizers
1.2.3 Spray or Coating-Based Stabilizers
1.2.4 Solid Phase Stabilizers
1.3 RNA Stabilizers by Application
1.3.1 Global RNA Stabilizers Market Value by Application: 2025 vs 2032
1.3.2 Molecular Biology
1.3.3 Genomics
1.4 Global RNA Stabilizers Market Size Estimates and Forecasts
1.4.1 Global RNA Stabilizers Revenue 2021–2032
1.4.2 Global RNA Stabilizers Sales 2021–2032
1.4.3 Global RNA Stabilizers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 RNA Stabilizers Market Competition by Manufacturers
2.1 Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
2.2 Global RNA Stabilizers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global RNA Stabilizers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
2.7 Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
2.8 Global RNA Stabilizers Market Competitive Situation and Trends
2.8.1 Global RNA Stabilizers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global RNA Stabilizers Players Market Share by Revenue
2.8.3 Global RNA Stabilizers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RNA Stabilizers Market Scenario by Region
3.1 Global RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global RNA Stabilizers Sales by Region: 2021–2032
3.2.1 Global RNA Stabilizers Sales by Region: 2021–2026
3.2.2 Global RNA Stabilizers Sales by Region: 2027–2032
3.3 Global RNA Stabilizers Revenue by Region: 2021–2032
3.3.1 Global RNA Stabilizers Revenue by Region: 2021–2026
3.3.2 Global RNA Stabilizers Revenue by Region: 2027–2032
3.4 North America RNA Stabilizers Market Facts & Figures by Country
3.4.1 North America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America RNA Stabilizers Sales by Country (2021–2032)
3.4.3 North America RNA Stabilizers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe RNA Stabilizers Market Facts & Figures by Country
3.5.1 Europe RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe RNA Stabilizers Sales by Country (2021–2032)
3.5.3 Europe RNA Stabilizers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Stabilizers Market Facts & Figures by Region
3.6.1 Asia Pacific RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific RNA Stabilizers Sales by Region (2021–2032)
3.6.3 Asia Pacific RNA Stabilizers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RNA Stabilizers Market Facts & Figures by Country
3.7.1 Latin America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America RNA Stabilizers Sales by Country (2021–2032)
3.7.3 Latin America RNA Stabilizers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa RNA Stabilizers Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa RNA Stabilizers Sales by Country (2021–2032)
3.8.3 Middle East and Africa RNA Stabilizers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RNA Stabilizers Sales by Type (2021–2032)
4.1.1 Global RNA Stabilizers Sales by Type (2021–2026)
4.1.2 Global RNA Stabilizers Sales by Type (2027–2032)
4.1.3 Global RNA Stabilizers Sales Market Share by Type (2021–2032)
4.2 Global RNA Stabilizers Revenue by Type (2021–2032)
4.2.1 Global RNA Stabilizers Revenue by Type (2021–2026)
4.2.2 Global RNA Stabilizers Revenue by Type (2027–2032)
4.2.3 Global RNA Stabilizers Revenue Market Share by Type (2021–2032)
4.3 Global RNA Stabilizers Price by Type (2021–2032)
5 Segment by Application
5.1 Global RNA Stabilizers Sales by Application (2021–2032)
5.1.1 Global RNA Stabilizers Sales by Application (2021–2026)
5.1.2 Global RNA Stabilizers Sales by Application (2027–2032)
5.1.3 Global RNA Stabilizers Sales Market Share by Application (2021–2032)
5.2 Global RNA Stabilizers Revenue by Application (2021–2032)
5.2.1 Global RNA Stabilizers Revenue by Application (2021–2026)
5.2.2 Global RNA Stabilizers Revenue by Application (2027–2032)
5.2.3 Global RNA Stabilizers Revenue Market Share by Application (2021–2032)
5.3 Global RNA Stabilizers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck RNA Stabilizers Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Takara Bio
6.3.1 Takara Bio Company Information
6.3.2 Takara Bio Description and Business Overview
6.3.3 Takara Bio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Takara Bio RNA Stabilizers Product Portfolio
6.3.5 Takara Bio Recent Developments/Updates
6.4 Zymo Research
6.4.1 Zymo Research Company Information
6.4.2 Zymo Research Description and Business Overview
6.4.3 Zymo Research RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zymo Research RNA Stabilizers Product Portfolio
6.4.5 Zymo Research Recent Developments/Updates
6.5 NZYtech
6.5.1 NZYtech Company Information
6.5.2 NZYtech Description and Business Overview
6.5.3 NZYtech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 NZYtech RNA Stabilizers Product Portfolio
6.5.5 NZYtech Recent Developments/Updates
6.6 Omega Bio-Tek
6.6.1 Omega Bio-Tek Company Information
6.6.2 Omega Bio-Tek Description and Business Overview
6.6.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
6.6.5 Omega Bio-Tek Recent Developments/Updates
6.7 Vazyme
6.7.1 Vazyme Company Information
6.7.2 Vazyme Description and Business Overview
6.7.3 Vazyme RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Vazyme RNA Stabilizers Product Portfolio
6.7.5 Vazyme Recent Developments/Updates
6.8 BioEntist
6.8.1 BioEntist Company Information
6.8.2 BioEntist Description and Business Overview
6.8.3 BioEntist RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioEntist RNA Stabilizers Product Portfolio
6.8.5 BioEntist Recent Developments/Updates
6.9 Genetix Biotech Asia
6.9.1 Genetix Biotech Asia Company Information
6.9.2 Genetix Biotech Asia Description and Business Overview
6.9.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
6.9.5 Genetix Biotech Asia Recent Developments/Updates
6.10 SRL
6.10.1 SRL Company Information
6.10.2 SRL Description and Business Overview
6.10.3 SRL RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SRL RNA Stabilizers Product Portfolio
6.10.5 SRL Recent Developments/Updates
6.11 G-Biosciences
6.11.1 G-Biosciences Company Information
6.11.2 G-Biosciences Description and Business Overview
6.11.3 G-Biosciences RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 G-Biosciences RNA Stabilizers Product Portfolio
6.11.5 G-Biosciences Recent Developments/Updates
6.12 New England Biolabs
6.12.1 New England Biolabs Company Information
6.12.2 New England Biolabs Description and Business Overview
6.12.3 New England Biolabs RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 New England Biolabs RNA Stabilizers Product Portfolio
6.12.5 New England Biolabs Recent Developments/Updates
6.13 Dutscher
6.13.1 Dutscher Company Information
6.13.2 Dutscher Description and Business Overview
6.13.3 Dutscher RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dutscher RNA Stabilizers Product Portfolio
6.13.5 Dutscher Recent Developments/Updates
6.14 NCM Biotech
6.14.1 NCM Biotech Company Information
6.14.2 NCM Biotech Description and Business Overview
6.14.3 NCM Biotech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 NCM Biotech RNA Stabilizers Product Portfolio
6.14.5 NCM Biotech Recent Developments/Updates
6.15 Beyotime
6.15.1 Beyotime Company Information
6.15.2 Beyotime Description and Business Overview
6.15.3 Beyotime RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beyotime RNA Stabilizers Product Portfolio
6.15.5 Beyotime Recent Developments/Updates
6.16 Yeasen
6.16.1 Yeasen Company Information
6.16.2 Yeasen Description and Business Overview
6.16.3 Yeasen RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Yeasen RNA Stabilizers Product Portfolio
6.16.5 Yeasen Recent Developments/Updates
6.17 YaJi Biological
6.17.1 YaJi Biological Company Information
6.17.2 YaJi Biological Description and Business Overview
6.17.3 YaJi Biological RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 YaJi Biological RNA Stabilizers Product Portfolio
6.17.5 YaJi Biological Recent Developments/Updates
6.18 Maokangbio
6.18.1 Maokangbio Company Information
6.18.2 Maokangbio Description and Business Overview
6.18.3 Maokangbio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Maokangbio RNA Stabilizers Product Portfolio
6.18.5 Maokangbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Stabilizers Industry Chain Analysis
7.2 RNA Stabilizers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Stabilizers Production Mode & Process Analysis
7.4 RNA Stabilizers Sales and Marketing
7.4.1 RNA Stabilizers Sales Channels
7.4.2 RNA Stabilizers Distributors
7.5 RNA Stabilizers Customer Analysis
8 RNA Stabilizers Market Dynamics
8.1 RNA Stabilizers Industry Trends
8.2 RNA Stabilizers Market Drivers
8.3 RNA Stabilizers Market Challenges
8.4 RNA Stabilizers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 RNA Stabilizers by Type
1.2.1 Global RNA Stabilizers Market Value by Type: 2025 vs 2032
1.2.2 Solution-Based Stabilizers
1.2.3 Spray or Coating-Based Stabilizers
1.2.4 Solid Phase Stabilizers
1.3 RNA Stabilizers by Application
1.3.1 Global RNA Stabilizers Market Value by Application: 2025 vs 2032
1.3.2 Molecular Biology
1.3.3 Genomics
1.4 Global RNA Stabilizers Market Size Estimates and Forecasts
1.4.1 Global RNA Stabilizers Revenue 2021–2032
1.4.2 Global RNA Stabilizers Sales 2021–2032
1.4.3 Global RNA Stabilizers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 RNA Stabilizers Market Competition by Manufacturers
2.1 Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
2.2 Global RNA Stabilizers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global RNA Stabilizers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
2.7 Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
2.8 Global RNA Stabilizers Market Competitive Situation and Trends
2.8.1 Global RNA Stabilizers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global RNA Stabilizers Players Market Share by Revenue
2.8.3 Global RNA Stabilizers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RNA Stabilizers Market Scenario by Region
3.1 Global RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global RNA Stabilizers Sales by Region: 2021–2032
3.2.1 Global RNA Stabilizers Sales by Region: 2021–2026
3.2.2 Global RNA Stabilizers Sales by Region: 2027–2032
3.3 Global RNA Stabilizers Revenue by Region: 2021–2032
3.3.1 Global RNA Stabilizers Revenue by Region: 2021–2026
3.3.2 Global RNA Stabilizers Revenue by Region: 2027–2032
3.4 North America RNA Stabilizers Market Facts & Figures by Country
3.4.1 North America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America RNA Stabilizers Sales by Country (2021–2032)
3.4.3 North America RNA Stabilizers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe RNA Stabilizers Market Facts & Figures by Country
3.5.1 Europe RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe RNA Stabilizers Sales by Country (2021–2032)
3.5.3 Europe RNA Stabilizers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Stabilizers Market Facts & Figures by Region
3.6.1 Asia Pacific RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific RNA Stabilizers Sales by Region (2021–2032)
3.6.3 Asia Pacific RNA Stabilizers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RNA Stabilizers Market Facts & Figures by Country
3.7.1 Latin America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America RNA Stabilizers Sales by Country (2021–2032)
3.7.3 Latin America RNA Stabilizers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa RNA Stabilizers Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa RNA Stabilizers Sales by Country (2021–2032)
3.8.3 Middle East and Africa RNA Stabilizers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RNA Stabilizers Sales by Type (2021–2032)
4.1.1 Global RNA Stabilizers Sales by Type (2021–2026)
4.1.2 Global RNA Stabilizers Sales by Type (2027–2032)
4.1.3 Global RNA Stabilizers Sales Market Share by Type (2021–2032)
4.2 Global RNA Stabilizers Revenue by Type (2021–2032)
4.2.1 Global RNA Stabilizers Revenue by Type (2021–2026)
4.2.2 Global RNA Stabilizers Revenue by Type (2027–2032)
4.2.3 Global RNA Stabilizers Revenue Market Share by Type (2021–2032)
4.3 Global RNA Stabilizers Price by Type (2021–2032)
5 Segment by Application
5.1 Global RNA Stabilizers Sales by Application (2021–2032)
5.1.1 Global RNA Stabilizers Sales by Application (2021–2026)
5.1.2 Global RNA Stabilizers Sales by Application (2027–2032)
5.1.3 Global RNA Stabilizers Sales Market Share by Application (2021–2032)
5.2 Global RNA Stabilizers Revenue by Application (2021–2032)
5.2.1 Global RNA Stabilizers Revenue by Application (2021–2026)
5.2.2 Global RNA Stabilizers Revenue by Application (2027–2032)
5.2.3 Global RNA Stabilizers Revenue Market Share by Application (2021–2032)
5.3 Global RNA Stabilizers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck RNA Stabilizers Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Takara Bio
6.3.1 Takara Bio Company Information
6.3.2 Takara Bio Description and Business Overview
6.3.3 Takara Bio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Takara Bio RNA Stabilizers Product Portfolio
6.3.5 Takara Bio Recent Developments/Updates
6.4 Zymo Research
6.4.1 Zymo Research Company Information
6.4.2 Zymo Research Description and Business Overview
6.4.3 Zymo Research RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zymo Research RNA Stabilizers Product Portfolio
6.4.5 Zymo Research Recent Developments/Updates
6.5 NZYtech
6.5.1 NZYtech Company Information
6.5.2 NZYtech Description and Business Overview
6.5.3 NZYtech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 NZYtech RNA Stabilizers Product Portfolio
6.5.5 NZYtech Recent Developments/Updates
6.6 Omega Bio-Tek
6.6.1 Omega Bio-Tek Company Information
6.6.2 Omega Bio-Tek Description and Business Overview
6.6.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
6.6.5 Omega Bio-Tek Recent Developments/Updates
6.7 Vazyme
6.7.1 Vazyme Company Information
6.7.2 Vazyme Description and Business Overview
6.7.3 Vazyme RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Vazyme RNA Stabilizers Product Portfolio
6.7.5 Vazyme Recent Developments/Updates
6.8 BioEntist
6.8.1 BioEntist Company Information
6.8.2 BioEntist Description and Business Overview
6.8.3 BioEntist RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioEntist RNA Stabilizers Product Portfolio
6.8.5 BioEntist Recent Developments/Updates
6.9 Genetix Biotech Asia
6.9.1 Genetix Biotech Asia Company Information
6.9.2 Genetix Biotech Asia Description and Business Overview
6.9.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
6.9.5 Genetix Biotech Asia Recent Developments/Updates
6.10 SRL
6.10.1 SRL Company Information
6.10.2 SRL Description and Business Overview
6.10.3 SRL RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SRL RNA Stabilizers Product Portfolio
6.10.5 SRL Recent Developments/Updates
6.11 G-Biosciences
6.11.1 G-Biosciences Company Information
6.11.2 G-Biosciences Description and Business Overview
6.11.3 G-Biosciences RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 G-Biosciences RNA Stabilizers Product Portfolio
6.11.5 G-Biosciences Recent Developments/Updates
6.12 New England Biolabs
6.12.1 New England Biolabs Company Information
6.12.2 New England Biolabs Description and Business Overview
6.12.3 New England Biolabs RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 New England Biolabs RNA Stabilizers Product Portfolio
6.12.5 New England Biolabs Recent Developments/Updates
6.13 Dutscher
6.13.1 Dutscher Company Information
6.13.2 Dutscher Description and Business Overview
6.13.3 Dutscher RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dutscher RNA Stabilizers Product Portfolio
6.13.5 Dutscher Recent Developments/Updates
6.14 NCM Biotech
6.14.1 NCM Biotech Company Information
6.14.2 NCM Biotech Description and Business Overview
6.14.3 NCM Biotech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 NCM Biotech RNA Stabilizers Product Portfolio
6.14.5 NCM Biotech Recent Developments/Updates
6.15 Beyotime
6.15.1 Beyotime Company Information
6.15.2 Beyotime Description and Business Overview
6.15.3 Beyotime RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beyotime RNA Stabilizers Product Portfolio
6.15.5 Beyotime Recent Developments/Updates
6.16 Yeasen
6.16.1 Yeasen Company Information
6.16.2 Yeasen Description and Business Overview
6.16.3 Yeasen RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Yeasen RNA Stabilizers Product Portfolio
6.16.5 Yeasen Recent Developments/Updates
6.17 YaJi Biological
6.17.1 YaJi Biological Company Information
6.17.2 YaJi Biological Description and Business Overview
6.17.3 YaJi Biological RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 YaJi Biological RNA Stabilizers Product Portfolio
6.17.5 YaJi Biological Recent Developments/Updates
6.18 Maokangbio
6.18.1 Maokangbio Company Information
6.18.2 Maokangbio Description and Business Overview
6.18.3 Maokangbio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Maokangbio RNA Stabilizers Product Portfolio
6.18.5 Maokangbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Stabilizers Industry Chain Analysis
7.2 RNA Stabilizers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Stabilizers Production Mode & Process Analysis
7.4 RNA Stabilizers Sales and Marketing
7.4.1 RNA Stabilizers Sales Channels
7.4.2 RNA Stabilizers Distributors
7.5 RNA Stabilizers Customer Analysis
8 RNA Stabilizers Market Dynamics
8.1 RNA Stabilizers Industry Trends
8.2 RNA Stabilizers Market Drivers
8.3 RNA Stabilizers Market Challenges
8.4 RNA Stabilizers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global RNA Stabilizers Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global RNA Stabilizers Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global RNA Stabilizers Market Competitive Situation by Manufacturers in 2025
Table 4. Global RNA Stabilizers Sales (L) of Key Manufacturers (2021–2026)
Table 5. Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
Table 6. Global RNA Stabilizers Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global RNA Stabilizers Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market RNA Stabilizers Average Price (US$/mL) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
Table 12. Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA Stabilizers Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Stabilizers Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global RNA Stabilizers Sales by Region (L), 2021–2026
Table 18. Global RNA Stabilizers Sales Market Share by Region (2021–2026)
Table 19. Global RNA Stabilizers Sales by Region (L), 2027–2032
Table 20. Global RNA Stabilizers Sales Market Share by Region (2027–2032)
Table 21. Global RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
Table 22. Global RNA Stabilizers Revenue Market Share by Region (2021–2026)
Table 23. Global RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
Table 24. Global RNA Stabilizers Revenue Market Share by Region (2027–2032)
Table 25. North America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America RNA Stabilizers Sales by Country (L), 2021–2026
Table 27. North America RNA Stabilizers Sales by Country (L), 2027–2032
Table 28. North America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 29. North America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 30. Europe RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe RNA Stabilizers Sales by Country (L), 2021–2026
Table 32. Europe RNA Stabilizers Sales by Country (L), 2027–2032
Table 33. Europe RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 34. Europe RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific RNA Stabilizers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific RNA Stabilizers Sales by Region (L), 2021–2026
Table 37. Asia Pacific RNA Stabilizers Sales by Region (L), 2027–2032
Table 38. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America RNA Stabilizers Sales by Country (L), 2021–2026
Table 42. Latin America RNA Stabilizers Sales by Country (L), 2027–2032
Table 43. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa RNA Stabilizers Sales by Country (L), 2021–2026
Table 47. Middle East and Africa RNA Stabilizers Sales by Country (L), 2027–2032
Table 48. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 50. Global RNA Stabilizers Sales (L) by Type (2021–2026)
Table 51. Global RNA Stabilizers Sales (L) by Type (2027–2032)
Table 52. Global RNA Stabilizers Sales Market Share by Type (2021–2026)
Table 53. Global RNA Stabilizers Sales Market Share by Type (2027–2032)
Table 54. Global RNA Stabilizers Revenue (US$ Million) by Type (2021–2026)
Table 55. Global RNA Stabilizers Revenue (US$ Million) by Type (2027–2032)
Table 56. Global RNA Stabilizers Revenue Market Share by Type (2021–2026)
Table 57. Global RNA Stabilizers Revenue Market Share by Type (2027–2032)
Table 58. Global RNA Stabilizers Price (US$/mL) by Type (2021–2026)
Table 59. Global RNA Stabilizers Price (US$/mL) by Type (2027–2032)
Table 60. Global RNA Stabilizers Sales (L) by Application (2021–2026)
Table 61. Global RNA Stabilizers Sales (L) by Application (2027–2032)
Table 62. Global RNA Stabilizers Sales Market Share by Application (2021–2026)
Table 63. Global RNA Stabilizers Sales Market Share by Application (2027–2032)
Table 64. Global RNA Stabilizers Revenue (US$ Million) by Application (2021–2026)
Table 65. Global RNA Stabilizers Revenue (US$ Million) by Application (2027–2032)
Table 66. Global RNA Stabilizers Revenue Market Share by Application (2021–2026)
Table 67. Global RNA Stabilizers Revenue Market Share by Application (2027–2032)
Table 68. Global RNA Stabilizers Price (US$/mL) by Application (2021–2026)
Table 69. Global RNA Stabilizers Price (US$/mL) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 73. Merck RNA Stabilizers Product
Table 74. Merck Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 78. Thermo Fisher Scientific RNA Stabilizers Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. Takara Bio Company Information
Table 81. Takara Bio Description and Business Overview
Table 82. Takara Bio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 83. Takara Bio RNA Stabilizers Product
Table 84. Takara Bio Recent Developments/Updates
Table 85. Zymo Research Company Information
Table 86. Zymo Research Description and Business Overview
Table 87. Zymo Research RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 88. Zymo Research RNA Stabilizers Product
Table 89. Zymo Research Recent Developments/Updates
Table 90. NZYtech Company Information
Table 91. NZYtech Description and Business Overview
Table 92. NZYtech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 93. NZYtech RNA Stabilizers Product
Table 94. NZYtech Recent Developments/Updates
Table 95. Omega Bio-Tek Company Information
Table 96. Omega Bio-Tek Description and Business Overview
Table 97. Omega Bio-Tek RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 98. Omega Bio-Tek RNA Stabilizers Product
Table 99. Omega Bio-Tek Recent Developments/Updates
Table 100. Vazyme Company Information
Table 101. Vazyme Description and Business Overview
Table 102. Vazyme RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 103. Vazyme RNA Stabilizers Product
Table 104. Vazyme Recent Developments/Updates
Table 105. BioEntist Company Information
Table 106. BioEntist Description and Business Overview
Table 107. BioEntist RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 108. BioEntist RNA Stabilizers Product
Table 109. BioEntist Recent Developments/Updates
Table 110. Genetix Biotech Asia Company Information
Table 111. Genetix Biotech Asia Description and Business Overview
Table 112. Genetix Biotech Asia RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 113. Genetix Biotech Asia RNA Stabilizers Product
Table 114. Genetix Biotech Asia Recent Developments/Updates
Table 115. SRL Company Information
Table 116. SRL Description and Business Overview
Table 117. SRL RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 118. SRL RNA Stabilizers Product
Table 119. SRL Recent Developments/Updates
Table 120. G-Biosciences Company Information
Table 121. G-Biosciences Description and Business Overview
Table 122. G-Biosciences RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 123. G-Biosciences RNA Stabilizers Product
Table 124. G-Biosciences Recent Developments/Updates
Table 125. New England Biolabs Company Information
Table 126. New England Biolabs Description and Business Overview
Table 127. New England Biolabs RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 128. New England Biolabs RNA Stabilizers Product
Table 129. New England Biolabs Recent Developments/Updates
Table 130. Dutscher Company Information
Table 131. Dutscher Description and Business Overview
Table 132. Dutscher RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 133. Dutscher RNA Stabilizers Product
Table 134. Dutscher Recent Developments/Updates
Table 135. NCM Biotech Company Information
Table 136. NCM Biotech Description and Business Overview
Table 137. NCM Biotech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 138. NCM Biotech RNA Stabilizers Product
Table 139. NCM Biotech Recent Developments/Updates
Table 140. Beyotime Company Information
Table 141. Beyotime Description and Business Overview
Table 142. Beyotime RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 143. Beyotime RNA Stabilizers Product
Table 144. Beyotime Recent Developments/Updates
Table 145. Yeasen Company Information
Table 146. Yeasen Description and Business Overview
Table 147. Yeasen RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 148. Yeasen RNA Stabilizers Product
Table 149. Yeasen Recent Developments/Updates
Table 150. YaJi Biological Company Information
Table 151. YaJi Biological Description and Business Overview
Table 152. YaJi Biological RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 153. YaJi Biological RNA Stabilizers Product
Table 154. YaJi Biological Recent Developments/Updates
Table 155. Maokangbio Company Information
Table 156. Maokangbio Description and Business Overview
Table 157. Maokangbio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 158. Maokangbio RNA Stabilizers Product
Table 159. Maokangbio Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. RNA Stabilizers Distributors List
Table 163. RNA Stabilizers Customers List
Table 164. RNA Stabilizers Market Trends
Table 165. RNA Stabilizers Market Drivers
Table 166. RNA Stabilizers Market Challenges
Table 167. RNA Stabilizers Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of RNA Stabilizers
Figure 2. Global RNA Stabilizers Market Value by Type (US$ Million), 2021–2032
Figure 3. Global RNA Stabilizers Market Share by Type: 2025 & 2032
Figure 4. Solution-Based Stabilizers Product Picture
Figure 5. Spray or Coating-Based Stabilizers Product Picture
Figure 6. Solid Phase Stabilizers Product Picture
Figure 7. Global RNA Stabilizers Market Value by Application (US$ Million), 2021–2032
Figure 8. Global RNA Stabilizers Market Share by Application: 2025 & 2032
Figure 9. Molecular Biology
Figure 10. Genomics
Figure 11. Global RNA Stabilizers Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global RNA Stabilizers Market Size (US$ Million), 2021–2032
Figure 13. Global RNA Stabilizers Sales (L), 2021–2032
Figure 14. Global RNA Stabilizers Average Price (US$/mL), 2021–2032
Figure 15. RNA Stabilizers Report Years Considered
Figure 16. RNA Stabilizers Sales Share by Manufacturers in 2025
Figure 17. Global RNA Stabilizers Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global RNA Stabilizers Players: Market Share by Revenue in RNA Stabilizers in 2025
Figure 19. RNA Stabilizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 22. North America RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 23. United States RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 26. Europe RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 27. Germany RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific RNA Stabilizers Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific RNA Stabilizers Revenue Market Share by Region (2021–2032)
Figure 34. China RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 42. Latin America RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 43. Mexico RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 49. Turkey RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of RNA Stabilizers by Type (2021–2032)
Figure 53. Global Revenue Market Share of RNA Stabilizers by Type (2021–2032)
Figure 54. Global RNA Stabilizers Price (US$/mL) by Type (2021–2032)
Figure 55. Global Sales Market Share of RNA Stabilizers by Application (2021–2032)
Figure 56. Global Revenue Market Share of RNA Stabilizers by Application (2021–2032)
Figure 57. Global RNA Stabilizers Price (US$/mL) by Application (2021–2032)
Figure 58. RNA Stabilizers Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global RNA Stabilizers Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global RNA Stabilizers Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global RNA Stabilizers Market Competitive Situation by Manufacturers in 2025
Table 4. Global RNA Stabilizers Sales (L) of Key Manufacturers (2021–2026)
Table 5. Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
Table 6. Global RNA Stabilizers Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global RNA Stabilizers Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market RNA Stabilizers Average Price (US$/mL) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
Table 12. Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA Stabilizers Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Stabilizers Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global RNA Stabilizers Sales by Region (L), 2021–2026
Table 18. Global RNA Stabilizers Sales Market Share by Region (2021–2026)
Table 19. Global RNA Stabilizers Sales by Region (L), 2027–2032
Table 20. Global RNA Stabilizers Sales Market Share by Region (2027–2032)
Table 21. Global RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
Table 22. Global RNA Stabilizers Revenue Market Share by Region (2021–2026)
Table 23. Global RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
Table 24. Global RNA Stabilizers Revenue Market Share by Region (2027–2032)
Table 25. North America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America RNA Stabilizers Sales by Country (L), 2021–2026
Table 27. North America RNA Stabilizers Sales by Country (L), 2027–2032
Table 28. North America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 29. North America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 30. Europe RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe RNA Stabilizers Sales by Country (L), 2021–2026
Table 32. Europe RNA Stabilizers Sales by Country (L), 2027–2032
Table 33. Europe RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 34. Europe RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific RNA Stabilizers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific RNA Stabilizers Sales by Region (L), 2021–2026
Table 37. Asia Pacific RNA Stabilizers Sales by Region (L), 2027–2032
Table 38. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America RNA Stabilizers Sales by Country (L), 2021–2026
Table 42. Latin America RNA Stabilizers Sales by Country (L), 2027–2032
Table 43. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa RNA Stabilizers Sales by Country (L), 2021–2026
Table 47. Middle East and Africa RNA Stabilizers Sales by Country (L), 2027–2032
Table 48. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
Table 50. Global RNA Stabilizers Sales (L) by Type (2021–2026)
Table 51. Global RNA Stabilizers Sales (L) by Type (2027–2032)
Table 52. Global RNA Stabilizers Sales Market Share by Type (2021–2026)
Table 53. Global RNA Stabilizers Sales Market Share by Type (2027–2032)
Table 54. Global RNA Stabilizers Revenue (US$ Million) by Type (2021–2026)
Table 55. Global RNA Stabilizers Revenue (US$ Million) by Type (2027–2032)
Table 56. Global RNA Stabilizers Revenue Market Share by Type (2021–2026)
Table 57. Global RNA Stabilizers Revenue Market Share by Type (2027–2032)
Table 58. Global RNA Stabilizers Price (US$/mL) by Type (2021–2026)
Table 59. Global RNA Stabilizers Price (US$/mL) by Type (2027–2032)
Table 60. Global RNA Stabilizers Sales (L) by Application (2021–2026)
Table 61. Global RNA Stabilizers Sales (L) by Application (2027–2032)
Table 62. Global RNA Stabilizers Sales Market Share by Application (2021–2026)
Table 63. Global RNA Stabilizers Sales Market Share by Application (2027–2032)
Table 64. Global RNA Stabilizers Revenue (US$ Million) by Application (2021–2026)
Table 65. Global RNA Stabilizers Revenue (US$ Million) by Application (2027–2032)
Table 66. Global RNA Stabilizers Revenue Market Share by Application (2021–2026)
Table 67. Global RNA Stabilizers Revenue Market Share by Application (2027–2032)
Table 68. Global RNA Stabilizers Price (US$/mL) by Application (2021–2026)
Table 69. Global RNA Stabilizers Price (US$/mL) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 73. Merck RNA Stabilizers Product
Table 74. Merck Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 78. Thermo Fisher Scientific RNA Stabilizers Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. Takara Bio Company Information
Table 81. Takara Bio Description and Business Overview
Table 82. Takara Bio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 83. Takara Bio RNA Stabilizers Product
Table 84. Takara Bio Recent Developments/Updates
Table 85. Zymo Research Company Information
Table 86. Zymo Research Description and Business Overview
Table 87. Zymo Research RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 88. Zymo Research RNA Stabilizers Product
Table 89. Zymo Research Recent Developments/Updates
Table 90. NZYtech Company Information
Table 91. NZYtech Description and Business Overview
Table 92. NZYtech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 93. NZYtech RNA Stabilizers Product
Table 94. NZYtech Recent Developments/Updates
Table 95. Omega Bio-Tek Company Information
Table 96. Omega Bio-Tek Description and Business Overview
Table 97. Omega Bio-Tek RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 98. Omega Bio-Tek RNA Stabilizers Product
Table 99. Omega Bio-Tek Recent Developments/Updates
Table 100. Vazyme Company Information
Table 101. Vazyme Description and Business Overview
Table 102. Vazyme RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 103. Vazyme RNA Stabilizers Product
Table 104. Vazyme Recent Developments/Updates
Table 105. BioEntist Company Information
Table 106. BioEntist Description and Business Overview
Table 107. BioEntist RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 108. BioEntist RNA Stabilizers Product
Table 109. BioEntist Recent Developments/Updates
Table 110. Genetix Biotech Asia Company Information
Table 111. Genetix Biotech Asia Description and Business Overview
Table 112. Genetix Biotech Asia RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 113. Genetix Biotech Asia RNA Stabilizers Product
Table 114. Genetix Biotech Asia Recent Developments/Updates
Table 115. SRL Company Information
Table 116. SRL Description and Business Overview
Table 117. SRL RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 118. SRL RNA Stabilizers Product
Table 119. SRL Recent Developments/Updates
Table 120. G-Biosciences Company Information
Table 121. G-Biosciences Description and Business Overview
Table 122. G-Biosciences RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 123. G-Biosciences RNA Stabilizers Product
Table 124. G-Biosciences Recent Developments/Updates
Table 125. New England Biolabs Company Information
Table 126. New England Biolabs Description and Business Overview
Table 127. New England Biolabs RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 128. New England Biolabs RNA Stabilizers Product
Table 129. New England Biolabs Recent Developments/Updates
Table 130. Dutscher Company Information
Table 131. Dutscher Description and Business Overview
Table 132. Dutscher RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 133. Dutscher RNA Stabilizers Product
Table 134. Dutscher Recent Developments/Updates
Table 135. NCM Biotech Company Information
Table 136. NCM Biotech Description and Business Overview
Table 137. NCM Biotech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 138. NCM Biotech RNA Stabilizers Product
Table 139. NCM Biotech Recent Developments/Updates
Table 140. Beyotime Company Information
Table 141. Beyotime Description and Business Overview
Table 142. Beyotime RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 143. Beyotime RNA Stabilizers Product
Table 144. Beyotime Recent Developments/Updates
Table 145. Yeasen Company Information
Table 146. Yeasen Description and Business Overview
Table 147. Yeasen RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 148. Yeasen RNA Stabilizers Product
Table 149. Yeasen Recent Developments/Updates
Table 150. YaJi Biological Company Information
Table 151. YaJi Biological Description and Business Overview
Table 152. YaJi Biological RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 153. YaJi Biological RNA Stabilizers Product
Table 154. YaJi Biological Recent Developments/Updates
Table 155. Maokangbio Company Information
Table 156. Maokangbio Description and Business Overview
Table 157. Maokangbio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 158. Maokangbio RNA Stabilizers Product
Table 159. Maokangbio Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. RNA Stabilizers Distributors List
Table 163. RNA Stabilizers Customers List
Table 164. RNA Stabilizers Market Trends
Table 165. RNA Stabilizers Market Drivers
Table 166. RNA Stabilizers Market Challenges
Table 167. RNA Stabilizers Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of RNA Stabilizers
Figure 2. Global RNA Stabilizers Market Value by Type (US$ Million), 2021–2032
Figure 3. Global RNA Stabilizers Market Share by Type: 2025 & 2032
Figure 4. Solution-Based Stabilizers Product Picture
Figure 5. Spray or Coating-Based Stabilizers Product Picture
Figure 6. Solid Phase Stabilizers Product Picture
Figure 7. Global RNA Stabilizers Market Value by Application (US$ Million), 2021–2032
Figure 8. Global RNA Stabilizers Market Share by Application: 2025 & 2032
Figure 9. Molecular Biology
Figure 10. Genomics
Figure 11. Global RNA Stabilizers Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global RNA Stabilizers Market Size (US$ Million), 2021–2032
Figure 13. Global RNA Stabilizers Sales (L), 2021–2032
Figure 14. Global RNA Stabilizers Average Price (US$/mL), 2021–2032
Figure 15. RNA Stabilizers Report Years Considered
Figure 16. RNA Stabilizers Sales Share by Manufacturers in 2025
Figure 17. Global RNA Stabilizers Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global RNA Stabilizers Players: Market Share by Revenue in RNA Stabilizers in 2025
Figure 19. RNA Stabilizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 22. North America RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 23. United States RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 26. Europe RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 27. Germany RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific RNA Stabilizers Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific RNA Stabilizers Revenue Market Share by Region (2021–2032)
Figure 34. China RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 42. Latin America RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 43. Mexico RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa RNA Stabilizers Revenue Market Share by Country (2021–2032)
Figure 49. Turkey RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of RNA Stabilizers by Type (2021–2032)
Figure 53. Global Revenue Market Share of RNA Stabilizers by Type (2021–2032)
Figure 54. Global RNA Stabilizers Price (US$/mL) by Type (2021–2032)
Figure 55. Global Sales Market Share of RNA Stabilizers by Application (2021–2032)
Figure 56. Global Revenue Market Share of RNA Stabilizers by Application (2021–2032)
Figure 57. Global RNA Stabilizers Price (US$/mL) by Application (2021–2032)
Figure 58. RNA Stabilizers Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232